Global Multiplex Assay Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Type;

Nucleic acid-based multiplex assays, Protein-based multiplex assays, and Others.

By Technology;

Multiplex PCR, Multiplex protein microarray, and Others.

By Application;

Companion Diagnostics, Research & Development. and Clinical Diagnostics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa. and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn137912471 Published Date: June, 2024 Updated Date: July, 2024

Introduction

Global Multiplex Assay Market (USD Million), 2020 - 2030

In the year 2023, the Global Multiplex Assay Market was valued at USD 1,450.30 million. The size of this market is expected to increase to USD 2,292.55 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.

The Global Multiplex Assay Market is experiencing significant growth, driven by the increasing demand for advanced diagnostic technologies and the rising prevalence of chronic diseases. Multiplex assays, which allow the simultaneous detection and quantification of multiple analytes in a single run, offer several advantages over traditional single-plex assays, including enhanced throughput, reduced sample volume requirements, and improved cost-efficiency. These assays are extensively used in various applications such as clinical diagnostics, drug development, and research, contributing to their widespread adoption in the healthcare and pharmaceutical industries.

The market has been segmented by type, application, technology, and geography. By type, it includes nucleic acid-based assays, protein-based assays, and others. In terms of application, the market covers research and development, clinical diagnostics, and companion diagnostics, among others. The technology segment encompasses PCR, flow cytometry, fluorescence-based techniques, and other methodologies. Geographically, the market is divided into five key regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

In recent years, technological advancements and innovations in multiplex assays have significantly enhanced their sensitivity, specificity, and reproducibility, making them indispensable tools in modern biomedical research and clinical practice. The integration of multiplex assays with automation and high-throughput screening systems further accelerates the pace of discovery and development in genomics, proteomics, and personalized medicine.

The growing emphasis on precision medicine and the need for comprehensive biomarker profiling are also fueling the demand for multiplex assays. These assays enable the identification and quantification of multiple biomarkers from a single sample, facilitating a more holistic understanding of disease mechanisms and improving the accuracy of diagnosis and prognosis.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Multiplex Assay Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising chronic diseases
        2. Demand for personalized medicine
        3. Biopharmaceutical growth
        4. Companion diagnostics adoption
        5. Genomics and proteomics advances
      2. Restraints
        1. Stringent regulations
        2. Limited standardization
        3. Data management challenges
        4. Intellectual property issues
        5. Sample quality variability
      3. Opportunities
        1. Novel biomarker development
        2. Academic-industry collaborations
        3. Infectious disease diagnostics
        4. Liquid biopsy applications
        5. Drug development use
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Multiplex Assay Market, By Type, 2020 - 2030 (USD Million)
      1. Nucleic acid-based multiplex assays
      2. Protein-based multiplex assays
      3. Others
    2. Global Multiplex Assay Market, By Technology, 2020 - 2030 (USD Million)
      1. Multiplex PCR
      2. Multiplex protein microarray
      3. Others
    3. Global Multiplex Assay Market, By Application, 2020 - 2030 (USD Million)
      1. Companion Diagnostics
      2. Research & Development
      3. Clinical Diagnostics
    4. Global Multiplex Assay Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Luminex Corporation (U.S.)
      2. Thermo Fisher Scientific Inc. (U.S.)
      3. Illumina, Inc (U.S.)
      4. Bio-Rad Laboratories, Inc. (U.S.)
      5. QIAGEN (Netherlands)
      6. Abcam plc (U.K.)
      7. BD (U.S.)
      8. Merck KGaA (Germany)
      9. Agilent Technologies, Inc. (U.S.)
      10. Meso Scale Diagnostics (U.S.)
      11. Randox Laboratories (U.K.)
      12. Quanterix (U.S.)
      13. Bio-Techne Corporation (U.S.)
      14. Olink (Sweden)
      15. DiaSorin S.p.A. (Italy)
      16. Seegene (South Korea)
      17. Promega Corporation (U.S.)
      18. Siemens (Germany)
      19. PerkinElmer, Inc. (U.S.)
      20. Shimadzu Corporation (Japan)
  7. Analyst Views
  8. Future Outlook of the Market